Immunotech Laboratories, Inc. (IMMB)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Jan 27, 2026
Immunotech Laboratories Market Cap
Immunotech Laboratories has a market cap or net worth of $57.5 thousand as of February 13, 2026. Its market cap has increased by 9,899.30% in one year.
Market Cap
57.50K
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since December 28, 2010, Immunotech Laboratories's market cap has decreased from 3.63M to 57.50K, a decrease of -98.42%. That is a compound annual growth rate of -24.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 57.50K | - |
| Dec 19, 2025 | 57.50K | - |
| Dec 19, 2023 | 57.50K | -50.00% |
| Dec 30, 2022 | 114.99K | -98.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Synairgen | 110.27K |
| Eastgate Biotech | 105.79K |
| Itoco | 85.64K |
| Vincerx Pharma | 65.43K |
| Affymax | 59.59K |
| Scorpius Holdings | 55.03K |
| Panbela Therapeutics | 53.89K |
| Mera Pharmaceuticals | 53.67K |